65 related articles for article (PubMed ID: 1972352)
21. Remote loading of preencapsulated drugs into stealth liposomes.
Sur S; Fries AC; Kinzler KW; Zhou S; Vogelstein B
Proc Natl Acad Sci U S A; 2014 Feb; 111(6):2283-8. PubMed ID: 24474802
[TBL] [Abstract][Full Text] [Related]
22. Permeability of membranes to amino acids and modified amino acids: Mechanisms involved in translocation.
Chakrabarti AC
Amino Acids; 1994 Oct; 6(3):213-29. PubMed ID: 24189731
[TBL] [Abstract][Full Text] [Related]
23. Complete regression of local cancer using temperature-sensitive liposomes combined with ultrasound-mediated hyperthermia.
Kheirolomoom A; Lai CY; Tam SM; Mahakian LM; Ingham ES; Watson KD; Ferrara KW
J Control Release; 2013 Nov; 172(1):266-273. PubMed ID: 23994755
[TBL] [Abstract][Full Text] [Related]
24. Objective: tumor. Strategies of drug targeting at the tumor mass level.
Martín Sabroso C; Torres-Suárez AI
Clin Transl Oncol; 2014 Jan; 16(1):1-10. PubMed ID: 23846244
[TBL] [Abstract][Full Text] [Related]
25. Enhanced cytotoxicity for colon 26 cells using doxorubicin-loaded sorbitan monooleate (Span 80) vesicles.
Hayashi K; Tatsui T; Shimanouchi T; Umakoshi H
Int J Biol Sci; 2013; 9(2):142-8. PubMed ID: 23411680
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of tumor vascular priming by a nanoparticulate doxorubicin formulation.
Roy Chaudhuri T; Arnold RD; Yang J; Turowski SG; Qu Y; Spernyak JA; Mazurchuk R; Mager DE; Straubinger RM
Pharm Res; 2012 Dec; 29(12):3312-24. PubMed ID: 22798260
[TBL] [Abstract][Full Text] [Related]
27. Physicochemical properties of epidermal growth factor receptor inhibitors and development of a nanoliposomal formulation of gefitinib.
Trummer BJ; Iyer V; Balu-Iyer SV; O'Connor R; Straubinger RM
J Pharm Sci; 2012 Aug; 101(8):2763-76. PubMed ID: 22581704
[TBL] [Abstract][Full Text] [Related]
28. Quantitative structure-property relationship modeling of remote liposome loading of drugs.
Cern A; Golbraikh A; Sedykh A; Tropsha A; Barenholz Y; Goldblum A
J Control Release; 2012 Jun; 160(2):147-57. PubMed ID: 22154932
[TBL] [Abstract][Full Text] [Related]
29. Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound.
Negussie AH; Yarmolenko PS; Partanen A; Ranjan A; Jacobs G; Woods D; Bryant H; Thomasson D; Dewhirst MW; Wood BJ; Dreher MR
Int J Hyperthermia; 2011; 27(2):140-55. PubMed ID: 21314334
[TBL] [Abstract][Full Text] [Related]
30. Copper-doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicity.
Kheirolomoom A; Mahakian LM; Lai CY; Lindfors HA; Seo JW; Paoli EE; Watson KD; Haynam EM; Ingham ES; Xing L; Cheng RH; Borowsky AD; Cardiff RD; Ferrara KW
Mol Pharm; 2010 Dec; 7(6):1948-58. PubMed ID: 20925429
[TBL] [Abstract][Full Text] [Related]
31. Comparative effects of thermosensitive doxorubicin-containing liposomes and hyperthermia in human and murine tumours.
Yarmolenko PS; Zhao Y; Landon C; Spasojevic I; Yuan F; Needham D; Viglianti BL; Dewhirst MW
Int J Hyperthermia; 2010; 26(5):485-98. PubMed ID: 20597627
[TBL] [Abstract][Full Text] [Related]
32. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.
Xu L; Anchordoquy T
J Pharm Sci; 2011 Jan; 100(1):38-52. PubMed ID: 20575003
[TBL] [Abstract][Full Text] [Related]
33. Conventional and dense gas techniques for the production of liposomes: a review.
Meure LA; Foster NR; Dehghani F
AAPS PharmSciTech; 2008; 9(3):798-809. PubMed ID: 18597175
[TBL] [Abstract][Full Text] [Related]
34. Determination of intraliposomal pH and its effect on membrane partitioning and passive loading of a hydrophobic camptothecin, DB-67.
Joguparthi V; Feng S; Anderson BD
Int J Pharm; 2008 Mar; 352(1-2):17-28. PubMed ID: 18065174
[TBL] [Abstract][Full Text] [Related]
35. A parenteral econazole formulation using a novel micelle-to-liposome transfer method: in vitro characterization and tumor growth delay in a breast cancer xenograft model.
Cogswell S; Berger S; Waterhouse D; Bally MB; Wasan EK
Pharm Res; 2006 Nov; 23(11):2575-85. PubMed ID: 17086505
[TBL] [Abstract][Full Text] [Related]
36. A new model of weak acid permeation through membranes revisited: does Overton still rule?
Saparov SM; Antonenko YN; Pohl P
Biophys J; 2006 Jun; 90(11):L86-8. PubMed ID: 16603491
[TBL] [Abstract][Full Text] [Related]
37. Effect of repetitive administration of Doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor model.
Arnold RD; Mager DE; Slack JE; Straubinger RM
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8856-65. PubMed ID: 16361575
[TBL] [Abstract][Full Text] [Related]
38. Quantification of Doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy.
Arnold RD; Slack JE; Straubinger RM
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 808(2):141-52. PubMed ID: 15261807
[TBL] [Abstract][Full Text] [Related]
39. Antibacterial efficacy against an in vivo Salmonella typhimurium infection model and pharmacokinetics of a liposomal ciprofloxacin formulation.
Webb MS; Boman NL; Wiseman DJ; Saxon D; Sutton K; Wong KF; Logan P; Hope MJ
Antimicrob Agents Chemother; 1998 Jan; 42(1):45-52. PubMed ID: 9449259
[TBL] [Abstract][Full Text] [Related]
40. Liposome-mediated therapy of intracranial brain tumors in a rat model.
Sharma US; Sharma A; Chau RI; Straubinger RM
Pharm Res; 1997 Aug; 14(8):992-8. PubMed ID: 9279878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
